DK267689A - Ikke-beta-oxiderbare fede syrer analoge med blodcholesterol- og -triglyceridsaenkende evne og praeparater indeholdende saadanne forbindelser - Google Patents

Ikke-beta-oxiderbare fede syrer analoge med blodcholesterol- og -triglyceridsaenkende evne og praeparater indeholdende saadanne forbindelser Download PDF

Info

Publication number
DK267689A
DK267689A DK267689A DK267689A DK267689A DK 267689 A DK267689 A DK 267689A DK 267689 A DK267689 A DK 267689A DK 267689 A DK267689 A DK 267689A DK 267689 A DK267689 A DK 267689A
Authority
DK
Denmark
Prior art keywords
compounds
triglyceride
beta
preparations containing
blood cholesterol
Prior art date
Application number
DK267689A
Other languages
Danish (da)
English (en)
Other versions
DK267689D0 (da
Inventor
Rolf K Berge
Jon Bremer
Original Assignee
Norsk Hydro As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro As filed Critical Norsk Hydro As
Publication of DK267689D0 publication Critical patent/DK267689D0/da
Publication of DK267689A publication Critical patent/DK267689A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK267689A 1988-06-02 1989-06-01 Ikke-beta-oxiderbare fede syrer analoge med blodcholesterol- og -triglyceridsaenkende evne og praeparater indeholdende saadanne forbindelser DK267689A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888813012A GB8813012D0 (en) 1988-06-02 1988-06-02 Non-b-oxidizable fatty acid analogues to reduce concentration of cholesterol & triglycerides in blood of mammals

Publications (2)

Publication Number Publication Date
DK267689D0 DK267689D0 (da) 1989-06-01
DK267689A true DK267689A (da) 1989-12-03

Family

ID=10637920

Family Applications (1)

Application Number Title Priority Date Filing Date
DK267689A DK267689A (da) 1988-06-02 1989-06-01 Ikke-beta-oxiderbare fede syrer analoge med blodcholesterol- og -triglyceridsaenkende evne og praeparater indeholdende saadanne forbindelser

Country Status (8)

Country Link
US (1) US5093365A (de)
EP (1) EP0345038B1 (de)
AT (1) ATE96664T1 (de)
CA (1) CA1329550C (de)
DE (1) DE68910386T2 (de)
DK (1) DK267689A (de)
ES (1) ES2059749T3 (de)
GB (1) GB8813012D0 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0869941B1 (de) 1994-10-13 2001-12-12 Peptech Limited Modifizierte mehrfach ungesättigte fettsäuren
NO952796D0 (no) * 1995-07-14 1995-07-14 Rolf Berge Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater
WO1999058120A1 (en) * 1998-05-08 1999-11-18 Rolf Berge USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS
US20020074691A1 (en) * 1999-09-14 2002-06-20 Robert M Mortellite High speed method of making plastic film and nonwoven laminates
AUPQ291499A0 (en) * 1999-09-17 1999-10-07 Women's And Children's Hospital Adelaide Novel nitro and sulphur containing compounds
NO328803B1 (no) * 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger
US6982251B2 (en) * 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
US20020147184A1 (en) * 2001-01-26 2002-10-10 Schering Corporation Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
CA2434488A1 (en) * 2001-01-26 2002-08-01 Harry R. Davis Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications
DK1385548T3 (da) * 2001-01-26 2007-09-10 Schering Corp Kombinationer af sterolabsorptionsinhibitor(er) med (et eller flere) kardiovaskulære midler til behandling af vaskulære tilstande
EP1785144A3 (de) * 2001-01-26 2007-05-23 Shering Corporation Kombinationen von Gallensäurebinder(n) und Sterolabsorptionshemmer(n) und entsprechende Behandlung für vaskuläre Indikationen
US20060287254A1 (en) * 2001-01-26 2006-12-21 Schering Corporation Use of substituted azetidinone compounds for the treatment of sitosterolemia
EP1911462A3 (de) 2001-01-26 2011-11-30 Schering Corporation Zusammensetzungen enthaltend einen Sterolabsorptionshemmer
US7071181B2 (en) * 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
JP4711600B2 (ja) * 2001-01-26 2011-06-29 シェーリング コーポレイション シトステロール血症の処置のための置換アゼチジノン化合物の使用
SI1413331T1 (sl) * 2001-01-26 2008-02-29 Schering Corp Kombinacije fenofibrata peroksisomskega proliferator aktivirajocega receptorja (PPAR) z ezetimib zaviralcem absorpcije sterola za vaskularne indikacije
WO2002096415A2 (en) * 2001-05-25 2002-12-05 Schering Corporation Use of azetidinone substituted derivatives in the treatment of alzheimer's disease
FR2828487B1 (fr) * 2001-08-09 2005-05-27 Genfit S A Nouveaux composes derives d'acides gras, preparation et utilisations
US7056906B2 (en) * 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
ATE411018T1 (de) * 2001-09-21 2008-10-15 Schering Corp Verfahren zur behandlung oder verhinderung von vaskulärer entzündung mit sterol-absorbierungs- inhibitor(en)
US20030119808A1 (en) * 2001-09-21 2003-06-26 Schering Corporation Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
US7132415B2 (en) * 2001-09-21 2006-11-07 Schering Corporation Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
RU2331649C2 (ru) * 2002-06-20 2008-08-20 Ай-Си Ви-И-Си Лимитед Серосодержащие фосфолипидные производные, содержащая их фармацевтическая композиция, их применение для лечения заболеваний и способ их получения
US20040067267A1 (en) * 2002-10-08 2004-04-08 Murthy Pothapragada Suryanarayana Process for preparation of cholesterol lowering compositions from garlic
CA2504878A1 (en) * 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorption inhibitors for the treatment of demyelination
CN100439361C (zh) 2003-03-07 2008-12-03 先灵公司 取代的2-吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
CN1756755A (zh) 2003-03-07 2006-04-05 先灵公司 取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
JP4589919B2 (ja) * 2003-03-07 2010-12-01 シェーリング コーポレイション 高コレステロール血症の処置のための、置換アゼチジノン化合物、これらの処方物および使用
US7459442B2 (en) * 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
EP1680189A2 (de) * 2003-11-05 2006-07-19 Schering Corporation Kombinationen von lipidmodulierenden mitteln mit substituierten azetidinonen zur behandlung von vaskularen erkrankungen
CA2554735A1 (en) * 2004-01-30 2005-08-11 Peplin Biolipids Pty Ltd Therapeutic and carrier molecules
CA2574366A1 (en) * 2004-07-19 2006-01-26 Thia Medica As Composition comprising plant and/or fish oils and compounds comprising non-oxidizable fatty acid entities
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US10154979B2 (en) 2013-03-11 2018-12-18 Sciadonics, Inc. Lipid compositions containing bioactive fatty acids
US20160024125A1 (en) 2013-03-11 2016-01-28 Life Science Nutrition As Natural lipids containing non-oxidizable fatty acids

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2208533A1 (de) * 1972-02-23 1973-09-27 Kolmar Laboratories Neue alkylthioaether
NL7405744A (en) * 1974-04-29 1975-10-31 Dow Chemical Co Butylphenyl-thioalkane carboxylic acids - as hypocholesterolaemics and antilipaemics from corresp. thiophenols and haloalkane carboxylic acids
DE2515146A1 (de) * 1975-04-08 1976-10-21 Bayer Ag Carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2856683A1 (de) * 1978-12-29 1980-07-17 Nattermann A & Cie Entzuendungshemmende und antiatherosklerotisch wirkende arzneimittel
CH661207A5 (en) * 1980-06-30 1987-07-15 Hoerrmann Wilhelm Pharmaceutical composition containing long-chain aldehydes or carboxylic acids

Also Published As

Publication number Publication date
ES2059749T3 (es) 1994-11-16
DE68910386D1 (de) 1993-12-09
DK267689D0 (da) 1989-06-01
DE68910386T2 (de) 1994-06-09
ATE96664T1 (de) 1993-11-15
GB8813012D0 (en) 1988-07-06
EP0345038A3 (de) 1991-06-12
EP0345038A2 (de) 1989-12-06
US5093365A (en) 1992-03-03
EP0345038B1 (de) 1993-11-03
CA1329550C (en) 1994-05-17

Similar Documents

Publication Publication Date Title
DK267689D0 (da) Ikke-beta-oxiderbare fede syrer analoge med blodcholesterol- og -triglyceridsaenkende evne og praeparater indeholdende saadanne forbindelser
HUT43599A (en) Process for production of derivatives of thiazolidindion and medical compounds containing those
DK139287A (da) Tertiaere hydroxyalkylxanthiner, deres fremstilling og anvendelse som laegemidler
SE8703625D0 (sv) New medical use
EP0430045A3 (en) Ascorbic acid tocopheryl phosphate diesters for inhibition of maillard's reaction
AU6567086A (en) Compositions and methods for the treatment of bleeding disorders
ZA899673B (en) Pyridinium polymers and their use as cholesterol lowering agents
GR3002618T3 (en) Solutions of oxazaphosphorins with enhanced stability and process for their preparation
DK337589A (da) 3r,s- og 3r-formerne af 3-substuerede 1-(2-aryl -eller heteroarylethyl)piperidin-forbindelser og deres anvendelse til fremstilling af et laegemiddel til behandling af sygdommme forbundet med aendret motilitet og/eller tonus af glatmuskel samt farmaceutiske praeparater indeholdende disse forbindelser
IE882529L (en) Platinum Coordination Compound
DK562488A (da) Farmaceutisk praeparat indeholdende polyminderivater, samt nogle af disse polyaminderivater
DK158950C (da) Substituerede 1,4-dihydropyridinlactoner og laegemiddel indeholdende disse
DK0488928T3 (da) Pharmaceutiske formuleringer, der indeholder en blanding af højere, primære, alifatiske alkoholer, til behandling af hyperc
ATE71092T1 (de) Hydroxybutenolid-derivate, ihre herstellung und ihre verwendung.
DK529585D0 (da) N-(6-methoxy-5-(perflouralkyl)-1-naphtholyl)-n-methylglyciner og deres thionaphthoyl analoge, deres fremstilling og anvendelse som laegemidler
DK248886D0 (da) Spiro-imidazolidin-forbindelser og farmaceutiske praeparater indeholdende disse
DK165981C (da) Isoxazolderivater, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse forbindelser
DK302486D0 (da) 11-substituerede 5,11-dihydro-6h-pyrido(2,3-b)(1,4)benzodiazepin-6-oner
ATE86498T1 (de) Verminderung des gehaltes an lipoproteine mit geringer dichte in biologischen fluessigkeiten.
IL89324A0 (en) Therapeutic agents for the treatment of peptic ulcer disease containing xanthine derivatives
KR910002456A (ko) 당뇨병 치료용 제약 조성물
NO931752D0 (no) Oktahydronaftalenoksimderivater til inhibering av kolesterolbiosyntese, samt fremgangsmaate til fremstilling og anvendelse derav
AU584098B2 (en) Substituted azabicycloheptanes, the use thereof, pharmaceutical preparations that contain these compounds, and processes for the manufacture of these compounds
GB2152508A (en) Pyrimidine derivatives
FR2558161B1 (fr) 3-alkoxy 2-(n-pyrrolidino) n-furylmethyl ou n-thienylmethyl n-pyridyl propylamines, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment